G. Planz

453 total citations
29 papers, 339 citations indexed

About

G. Planz is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Complementary and alternative medicine. According to data from OpenAlex, G. Planz has authored 29 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Physiology and 6 papers in Complementary and alternative medicine. Recurrent topics in G. Planz's work include Heart Rate Variability and Autonomic Control (6 papers), Cardiovascular and exercise physiology (5 papers) and Pharmacological Effects and Assays (5 papers). G. Planz is often cited by papers focused on Heart Rate Variability and Autonomic Control (6 papers), Cardiovascular and exercise physiology (5 papers) and Pharmacological Effects and Assays (5 papers). G. Planz collaborates with scholars based in Germany and Netherlands. G. Planz's co-authors include D. Palm, K. H. Rahn, Felix Kersting, H. Grobecker, E Appel, K. H. Rahn, Götz von Bernuth, Ercan Yılmaz, R. Heintz and Pelle Baggesgaard Petersen and has published in prestigious journals such as Cellular and Molecular Life Sciences, Journal of Molecular Medicine and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

G. Planz

28 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Planz Germany 10 90 79 67 57 43 29 339
A. Pinelli Italy 12 59 0.7× 132 1.7× 80 1.2× 66 1.2× 25 0.6× 66 434
Aado Vendsalu Sweden 6 98 1.1× 69 0.9× 51 0.8× 91 1.6× 73 1.7× 9 422
M. D. Galva Italy 12 116 1.3× 108 1.4× 107 1.6× 66 1.2× 40 0.9× 21 385
Concetta Harakal United States 14 142 1.6× 133 1.7× 113 1.7× 147 2.6× 45 1.0× 42 543
Franklin E. Roth United States 13 74 0.8× 130 1.6× 52 0.8× 84 1.5× 28 0.7× 22 501
Kanoo Hosoki Japan 11 93 1.0× 174 2.2× 55 0.8× 91 1.6× 33 0.8× 64 481
Theodore Koppányi United States 10 93 1.0× 82 1.0× 78 1.2× 59 1.0× 22 0.5× 51 494
L. E. Martin United Kingdom 8 64 0.7× 91 1.2× 34 0.5× 102 1.8× 31 0.7× 11 495
R. A. Ferrone United States 12 188 2.1× 140 1.8× 69 1.0× 94 1.6× 82 1.9× 13 498
Gooitzen Alberts Netherlands 9 143 1.6× 122 1.5× 32 0.5× 57 1.0× 28 0.7× 11 407

Countries citing papers authored by G. Planz

Since Specialization
Citations

This map shows the geographic impact of G. Planz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Planz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Planz more than expected).

Fields of papers citing papers by G. Planz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Planz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Planz. The network helps show where G. Planz may publish in the future.

Co-authorship network of co-authors of G. Planz

This figure shows the co-authorship network connecting the top 25 collaborators of G. Planz. A scholar is included among the top collaborators of G. Planz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Planz. G. Planz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Planz, G., et al.. (2008). Ist die Kombination von β-Blockern und Clonidin bei antihypertensiver Therapie gefährlich?. DMW - Deutsche Medizinische Wochenschrift. 106(19). 603–604.
2.
Planz, G., et al.. (1983). Plasma catecholamines in children. Cellular and Molecular Life Sciences. 39(8). 871–871. 6 indexed citations
3.
Planz, G., et al.. (1983). Plasma catecholamines in children. Cellular and Molecular Life Sciences. 39(5). 497–498. 4 indexed citations
4.
Planz, G., et al.. (1982). Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.. PubMed. 20(10). 469–73. 2 indexed citations
5.
Planz, G., et al.. (1982). Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.. PubMed. 20(10). 474–8. 2 indexed citations
6.
Planz, G., et al.. (1981). Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise. European Journal of Clinical Pharmacology. 19(2). 83–88. 11 indexed citations
7.
Planz, G., et al.. (1980). Influence of propranolol on catecholamine concentration in blood of normotensive man during physical exercise and dependence of the drug effect on dosage intervals.. PubMed. Suppl. 58–66. 3 indexed citations
8.
Planz, G., et al.. (1978). Adrenalin- und Noradrenalinkonzentration im Blut der Nebennieren- und Nierenvenen des Menschen bei normalem Blutdruck und bei essentieller Hypertonie. Journal of Molecular Medicine. 56(22). 1109–1112. 10 indexed citations
9.
Rahn, K. H., et al.. (1978). Studies on the effects of propranolol on plasma catecholamine levels in patients with essential hypertension. European Journal of Clinical Investigation. 8(3). 143–148. 30 indexed citations
10.
Planz, G., et al.. (1976). Zahl und Art von Arzneimittelnebenwirkungen in einer Medizinischen Klinik. DMW - Deutsche Medizinische Wochenschrift. 101(1). 9–13. 1 indexed citations
11.
12.
Planz, G., et al.. (1976). [Effect of the beta receptor blockader propranolol (Dociton) on the plasma concentration of catecholamines in patients with hypertension].. PubMed. 82 Pt 2. 1316–8. 2 indexed citations
13.
Planz, G., et al.. (1976). Plasma dopamine-?-hydroxylase activity and the pressor effect of dopamine infusion in man. European Journal of Clinical Pharmacology. 10(3-4). 197–200. 1 indexed citations
14.
Rahn, K. H., et al.. (1974). Studies on the antihypertensive action of the optical isomers of propranolol in man. Naunyn-Schmiedeberg s Archives of Pharmacology. 286(3). 319–323. 57 indexed citations
15.
Grobecker, H., et al.. (1974). [Determination of specific and nonspecific effect of beta-sympatholytic agents].. PubMed. 80. 258–60. 4 indexed citations
16.
Planz, G. & D. Palm. (1973). Acute enhancement of dopamine-?-hydroxylase activity in human plasma after maximum work load. European Journal of Clinical Pharmacology. 5(4). 255–258. 40 indexed citations
17.
Planz, G., et al.. (1973). On the evaluation of weak and reversible inhibitors of monoamine oxidase in vivo and in vitro. Investigations with diphenyl-piperidine derivatives.. PubMed. 23(2). 281–5. 3 indexed citations
18.
Appel, E, et al.. (1973). [Action mechanism of oxyfedrin (ildamen) in animal experiment and in man].. PubMed. 79. 1021–3. 2 indexed citations
19.
Appel, E, G. Planz, Benjamin Schmid, D. Palm, & H. Grobecker. (1973). Noradrenaline depleting effect and metabolism of oxyfedrine in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 280(4). 373–390. 3 indexed citations
20.
Palm, D., et al.. (1971). Quantitation of irreversible inhibition of monoamine oxidase in man. European Journal of Clinical Pharmacology. 3(2). 82–92. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Pinelli Breakdown of academic impact, for papers by Aado Vendsalu Breakdown of academic impact, for papers by M. D. Galva Breakdown of academic impact, for papers by Concetta Harakal Breakdown of academic impact, for papers by Franklin E. Roth Breakdown of academic impact, for papers by Kanoo Hosoki Breakdown of academic impact, for papers by Theodore Koppányi Breakdown of academic impact, for papers by L. E. Martin Breakdown of academic impact, for papers by R. A. Ferrone Breakdown of academic impact, for papers by Gooitzen Alberts
Rankless by CCL
2026